Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fampridine crossover study for upper limb function in progressive multiple sclerosis
2011-002561-38Phase 4Completed
- Sponsor
- St. Vincent's University Hospital
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dalfampridine in primary progressive multiple sclerosis (PPMS) and secondary-progressive multiple sclerosis (SPMS) (2 arms), sponsored by St. Vincent's University Hospital. Primary endpoint: Upper limb responder rate by 9-HPT. Started Feb 2012; status: completed.
02
Drugs
dalfampridine
03
Conditions
primary progressive multiple sclerosis (PPMS)secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on 2011-002561-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002561-38.